Sampson, ex-aide to Gonzales, joins law firm

Cedar City native known for his role in scandal over prosecutor firings
This is an archived article that was published on in 2007, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

Three Washington lawyers with Utah ties - including the chief of staff to former Attorney General Alberto Gonzales - are joining the food and drug practice at the firm Hunton & Williams.

D. Kyle Sampson, a Cedar City native, was Gonzales' chief of staff at the Justice Department until he resigned amid a controversy over the firing of eight U.S. Attorneys, a move that spawned congressional investigations. Sampson, who compiled the list of attorneys who were fired, testified for hours before House and Senate committees in public hearings and private interviews.

Before joining the Justice Department he was an Associate Counsel to the President at the White House, was director of personnel for the Bush administration, and was an aide to Sen. Orrin Hatch on the Judiciary Committee. He is a graduate of Brigham Young University and Chicago University law school.

Conan Grames was general counsel at Pharmaceutical Research and Manufacturers of America (PhRMA), the leading pharmaceutical industry association. Before that, he was head of the international law section at the Salt Lake City firm Kirton & McConkie and was a vice president with Bristol-Myers Squibb Co.

Grames is a graduate of the University of Utah and Harvard Law School.

Sheldon Bradshaw was most recently the chief counsel at the Food and Drug Administration, where he advised Health and Human Services Secretary Mike Leavitt and senior officials at HHS and FDA.

He was deputy assistant attorney general at the Justice Department's Office of Legal Counsel, which drafts legal opinions for the government, and was principal deputy assistant attorney general for civil rights at the department. He graduated from BYU and got his law degree at George Washington University.

The three will generally focus on issues under FDA's authority, such as food and drugs, dietary supplements and medical devices.